Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA: 603707)
China flag China · Delayed Price · Currency is CNY
14.53
-0.03 (-0.21%)
Nov 21, 2024, 9:51 AM CST

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
3,8693,9233,7083,6812,9112,467
Upgrade
Other Revenue
8.658.654.615.253.552.37
Upgrade
Revenue
3,8773,9313,7133,6872,9152,470
Upgrade
Revenue Growth (YoY)
-3.15%5.89%0.71%26.48%18.03%45.25%
Upgrade
Cost of Revenue
3,4923,2721,7781,6031,2361,204
Upgrade
Gross Profit
385.77659.141,9352,0831,6791,265
Upgrade
Selling, General & Admin
467.43566.47617.61606.05550.1419.3
Upgrade
Research & Development
375.72372.29263.66220.95187.53166.35
Upgrade
Other Operating Expenses
39.755.7330.9822.154.924.12
Upgrade
Operating Expenses
887.32991.45913851.58751.05592.94
Upgrade
Operating Income
-501.54-332.311,0221,232927.95672.4
Upgrade
Interest Expense
-76.45-81.05-57.85-92.22-57.57-22.09
Upgrade
Interest & Investment Income
11.8227.9860.7427.5311.6414.12
Upgrade
Currency Exchange Gain (Loss)
128.88128.88154.779.371.663.69
Upgrade
Other Non Operating Income (Expenses)
-145.72-1.35-0.65-2.74-7.04-0.75
Upgrade
EBT Excluding Unusual Items
-583.02-257.841,1791,174876.65667.37
Upgrade
Gain (Loss) on Sale of Investments
-68.69-91.74-5.069.090.4-
Upgrade
Gain (Loss) on Sale of Assets
-0.06-0.07-0.11-1.03-0.220.13
Upgrade
Other Unusual Items
106.9154.8912.0221.9837.812.87
Upgrade
Pretax Income
-544.86-294.761,1851,204914.63680.37
Upgrade
Income Tax Expense
-121.86-105.3198.85139.84117.9874.12
Upgrade
Earnings From Continuing Operations
-423-189.451,0871,064796.65606.24
Upgrade
Minority Interest in Earnings
0.0304.31-4.629.47-1.28
Upgrade
Net Income
-422.97-189.451,0911,059806.12604.96
Upgrade
Net Income to Common
-422.97-189.451,0911,059806.12604.96
Upgrade
Net Income Growth
--2.98%31.41%33.25%42.50%
Upgrade
Shares Outstanding (Basic)
1,5961,5791,6281,5811,5881,573
Upgrade
Shares Outstanding (Diluted)
1,5961,5791,6281,5811,5881,573
Upgrade
Shares Change (YoY)
-1.71%-3.03%2.98%-0.43%0.94%-0.52%
Upgrade
EPS (Basic)
-0.26-0.120.670.670.510.38
Upgrade
EPS (Diluted)
-0.26-0.120.670.670.510.38
Upgrade
EPS Growth
--0%31.97%32.01%43.24%
Upgrade
Free Cash Flow
853.111,200125.37242.87-860.21-956.79
Upgrade
Free Cash Flow Per Share
0.530.760.080.15-0.54-0.61
Upgrade
Dividend Per Share
0.1000.1000.1150.1150.0890.137
Upgrade
Dividend Growth
-13.04%-13.04%-0.35%29.95%-34.95%160.00%
Upgrade
Gross Margin
9.95%16.77%52.10%56.51%57.60%51.24%
Upgrade
Operating Margin
-12.93%-8.45%27.51%33.41%31.84%27.23%
Upgrade
Profit Margin
-10.91%-4.82%29.38%28.73%27.66%24.50%
Upgrade
Free Cash Flow Margin
22.00%30.53%3.38%6.59%-29.51%-38.74%
Upgrade
EBITDA
-341.18-180.871,1611,3251,013717.39
Upgrade
EBITDA Margin
-8.80%-4.60%31.27%35.94%34.74%29.05%
Upgrade
D&A For EBITDA
160.36151.44139.5393.2284.5544.99
Upgrade
EBIT
-501.54-332.311,0221,232927.95672.4
Upgrade
EBIT Margin
-12.93%-8.45%27.51%33.41%31.84%27.23%
Upgrade
Effective Tax Rate
--8.34%11.62%12.90%10.89%
Upgrade
Revenue as Reported
3,8773,9313,7133,6872,9152,470
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.